Moderate riskFDA DrugClass II

Amneal exenatide injection pens recalled for possible missing medication

Some prefilled pens of Amneal Exenatide Injection may contain no medication due to a defective delivery system. This affects lot AP250095A (expiration 2/28/2027). Patients relying on these pens may not receive their intended dose.

From the FDA notice · Read the official notice ↗ · All Amneal Pharmaceuticals recalls

What to do

  1. Check if your Exenatide Injection matches lot AP250095A (expiration 2/28/2027).
  2. Do not use the pen if you suspect it is defective or empty.
  3. Contact your pharmacy or doctor for a replacement or alternative diabetes medication.
  4. Report any problems with this medication to the FDA at 1-888-SAFEMEDS or online at fda.gov/medwatch.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
5,694 pens
Illnesses reported
None reported
Manufactured in
50 Horseblock Rd, Brookhaven, NY, United States
Classification
Class II
Recall number
D-0868-2026

In the FDA's words

Description
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1 Defective Delivery System: Possibility of no medication in the prefilled pen. Lot #: AP250095A, Exp 2/28/2027 Distribution: USA Nationwide Affected quantity: 5,694 pens
Hazard
Defective Delivery System: Possibility of no medication in the prefilled pen.

Related topics

PotencyDrugsSold nationwideMore from FDA Drug